|
1
|
Ahuja N: A Short Textbook of Psychiatry
(7th edition). Jaypee Brothers Medical Publishers, Ltd., New Delhi,
2011.
|
|
2
|
Allison DB, Mentore JL, Heo M, Chandler
LP, Cappelleri JC, Infante MC and Weiden PJ: Antipsychotic-induced
weight gain: A comprehensive research synthesis. Am J Psychiatry.
156:1686–1696. 1999.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Baptista T, Martínez J, Lacruz A, Rangel
N, Beaulieu S, Serrano A, Arapé Y, Martinez M, de Mendoza S, Teneud
L and Hernández L: Metformin for prevention of weight gain and
insulin resistance with olanzapine: A double-blind
placebo-controlled trial. Can J Psychiatry. 51:192–196.
2006.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Corcoran C and Jacobs TF: Metformin. In:
StatPearls. StatPearls Publishing, Treasure Island, FL, 2026.
|
|
5
|
Correll CU, Manu P, Olshanskiy V,
Napolitano B, Kane JM and Malhotra AK: Cardiometabolic risk of
second-generation antipsychotic medications during first-time use
in children and adolescents. JAMA. 302:1765–1773. 2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
De Hert M, Detraux J, van Winkel R, Yu W
and Correll CU: Metabolic and cardiovascular adverse effects
associated with antipsychotic drugs. Nat Rev Endocrinol. 8:114–126.
2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Correll CU, Solmi M, Veronese N, Bortolato
B, Rosson S, Santonastaso P, Thapa-Chhetri N, Fornaro M, Gallicchio
D, Collantoni E, et al: Prevalence, incidence and mortality from
cardiovascular disease in patients with pooled and specific severe
mental illness: A large-scale meta-analysis of 3,211,768 patients
and 113,383,368 controls. World Psychiatry. 16:163–180.
2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tek C, Kucukgoncu S, Guloksuz S, Woods SW,
Srihari VH and Annamalai A: Antipsychotic-induced weight gain in
first-episode psychosis patients: A meta-analysis of differential
effects of antipsychotic medications. Early Interv Psychiatry.
10:193–202. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Vancampfort D, Firth J, Schuch FB,
Rosenbaum S, Mugisha J, Hallgren M, Probst M, Ward PB, Gaughran F,
De Hert M, et al: Sedentary behavior and physical activity levels
in people with schizophrenia, bipolar disorder and major depressive
disorder: A global systematic review and meta-analysis. World
Psychiatry. 16:308–315. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Schuch FB, Vancampfort D, Richards J,
Rosenbaum S, Ward PB and Stubbs B: Exercise as a treatment for
depression: A meta-analysis adjusting for publication bias. J
Psychiatr Res. 77:42–51. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
lSayed NA, Aleppo G, Aroda VR, Bannuru RR,
Brown FM, Bruemmer D, Collins BS, Das SR, Hilliard ME, Isaacs D, et
al: 10. Cardiovascular disease and risk management: Standards of
care in diabetes-2023. Diabetes Care. 46 (Suppl 1):S158–S190.
2023.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Velligan DI, Weiden PJ, Sajatovic M, Scott
J, Carpenter D, Ross R and Docherty JP: Expert Consensus Panel on
Adherence Problems in Serious and Persistent Mental Illness. The
expert consensus guideline series: Adherence problems in patients
with serious and persistent mental illness. J Clin Psychiatry. 70
(Suppl 4):S1–S48. 2009.PubMed/NCBI
|
|
13
|
Fiedorowicz JG, Miller DD, Bishop JR,
Calarge CA, Ellingrod VL and Haynes WG: Systematic review and
meta-analysis of pharmacological interventions for weight gain from
antipsychotics and mood stabilizers. Curr Psychiatry Rev. 8:25–36.
2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Jones HM and Pilowsky LS: Dopamine and
antipsychotic drug action revisited. Br J Psychiatry. 181:271–275.
2002.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Malin SK and Kashyap SR: Effects of
metformin on weight loss: Potential mechanisms. Curr Opin
Endocrinol Diabetes Obes. 21:323–329. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Schwinghammer TL, DiPiro JT, Ellingrod VL
and DiPiro CV: McGraw Hill Medical: Pharmacotherapy Handbook (11th
edition). AccessPharmacy, 2021. Available: https://accesspharmacy.mhmedical.com/book.aspx?bookID=3012.
|
|
17
|
McGrath J, Saha S, Welham J, El Saadi O,
MacCauley C and Chant D: A systematic review of the incidence of
schizophrenia: The distribution of rates and the influence of sex,
urbanicity, migrant status and methodology. BMC Med.
2(13)2004.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Mizuno Y, Suzuki T, Nakagawa A, Yoshida K,
Mimura M, Fleischhacker WW and Uchida H: Pharmacological strategies
to counteract antipsychotic-induced weight gain and metabolic
adverse effects in schizophrenia: A systematic review and
meta-analysis. Schizophr Bull. 40:1385–1403. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Newcomer JW: Antipsychotic medications:
Metabolic and cardiovascular risk. J Clin Psychiatry. 68 (Suppl
4):S8–S13. 2007.PubMed/NCBI
|
|
20
|
Seifarth C, Schehler B and Schneider HJ:
Effectiveness of metformin on weight loss in non-diabetic
individuals with obesity. Exp Clin Endocrinol Diabetes. 121:27–31.
2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Jiang WL, Cai DB, Yin F, Zhang L, Zhao XW,
He J, Ng CH, Ungvari GS, Sim K, Hu ML, et al: Adjunctive metformin
for antipsychotic-induced dyslipidemia: a meta-analysis of
randomized, double-blind, placebo-controlled trials. Transl
Psychiatry. 10(117)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Rawani NS, Chan AW, Dursun SM and Baker
GB: The underlying neurobiological mechanisms of psychosis: Focus
on neurotransmission dysregulation, neuroinflammation, oxidative
stress, and mitochondrial dysfunction. Antioxidants (Basel).
13(709)2024.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Penninx BWJH and Lange SMM: Metabolic
syndrome in psychiatric patients: Overview, mechanisms, and
implications. Dialogues Clin Neurosci. 20:63–73. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
de Silva VA, Suraweera C, Ratnatunga SS,
Dayabandara M, Wanniarachchi N and Hanwella R: Metformin in
prevention and treatment of antipsychotic induced weight gain: A
systematic review and meta-analysis. BMC Psychiatry.
16(341)2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Pillinger T, McCutcheon RA, Vano L, Mizuno
Y, Arumuham A, Hindley G, Beck K, Natesan S, Efthimiou O, Cipriani
A and Howes OD: Comparative effects of 18 antipsychotics on
metabolic function in patients with schizophrenia, predictors of
metabolic dysregulation, and association with psychopathology: A
systematic review and network meta-analysis. Lancet Psychiatry.
7:64–77. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
American Diabetes Association Professional
Practice Committee. 9. Pharmacologic approaches to glycemic
treatment: Standards of care in diabetes-2024. Diabetes Care. 47
(Suppl 1):S158–S178. 2024.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Siskind DJ, Russell AW, Gamble C, Winckel
K, Mayfield K, Hollingworth S, Hickman I, Siskind V and Kisely S:
Treatment of clozapine-associated obesity and diabetes with
exenatide in adults with schizophrenia: A randomized controlled
trial (CODEX). Diabetes Obes Metab. 20:1050–1055. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Firth J, Siddiqi N, Koyanagi A, Siskind D,
Rosenbaum S, Galletly C, Allan S, Caneo C, Carney R, Carvalho AF,
et al: The Lancet Psychiatry Commission: A blueprint for protecting
physical health in people with mental illness. Lancet Psychiatry.
6:675–712. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Koomen LEM, van der Horst MZ, Deenik J and
Cahn W: Lifestyle interventions for people with a severe mental
illness living in supported housing: A systematic review and
meta-analysis. Front Psychiatry. 13(966029)2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Vancampfort D, Stubbs B, Mitchell AJ, De
Hert M, Wampers M, Ward PB, Rosenbaum S and Correll CU: Risk of
metabolic syndrome and its components in people with schizophrenia
and related psychotic disorders, bipolar disorder and major
depressive disorder: A systematic review and meta-analysis. World
Psychiatry. 14:339–347. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Dayabandara M, Hanwella R, Ratnatunga S,
Seneviratne S, Suraweera C and de Silva VA:
Antipsychotic-associated weight gain: Management strategies and
impact on treatment adherence. Neuropsychiatr Dis Treat.
13:2231–2241. 2017.PubMed/NCBI View Article : Google Scholar
|
